Financial Year |
March 31 2023 |
Monetary Funds |
27,252,449,394.41 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
381,293,950.30 |
Advances to Suppliers |
690,219,834.26 |
Other Receivables |
20,156,212,863.54 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
94,804,640,040.61 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
5,827,704,908.00 |
Total Current Assets |
149,220,183,284.31 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
14,549,682,608.07 |
Investment Properties |
33,648,786,535.99 |
Fixed Assetes |
3,467,786,370.23 |
Under-construction Projects |
2,248,281.92 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
1,629,039,205.08 |
R&D expenses |
-- |
Goodwill |
305,214,299.04 |
Long-Term Deferred and Prepaid Expenses |
111,698,945.53 |
Deferred Income Tax Assets |
1,608,191,608.25 |
Other Non-Current Assets |
1,026,145,934.96 |
Sub-Total of Non-Current Assets |
56,913,365,847.08 |
Total Assets |
206,133,549,131.39 |
Short-Term Loans |
2,932,971,650.56 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
13,030,164,313.85 |
Accounts Received In Advance |
318,788,649.08 |
Employee Compensation Payable |
303,983,061.20 |
Taxes Payable |
4,140,611,700.37 |
Interest Payable |
291,831,826.00 |
Dividend Payable |
261,431,940.06 |
Other payables |
24,154,739,825.11 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
9,044,036,410.33 |
Other Current Liabilities |
3,685,079,400.55 |
Sub-Total of Current Liabilities |
91,959,639,082.68 |
Long-term Loans |
48,955,261,553.64 |
Bonds Payable |
12,765,639,664.39 |
Long-Term Accounts Payable |
1,747,800,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
41,741,765.85 |
Deferred Income Tax Liabilities |
722,900,466.97 |
Other Non-Current Liabilities |
389,516,815.59 |
Sub-Total of Non-Current Liabilities |
66,132,828,917.55 |
Total Liabilities |
158,092,468,000.23 |
Paid-In Capital(Or Share Stock) |
4,286,313,339.00 |
Capital Surplus |
8,639,669,848.69 |
Surplus Reserve |
1,268,598,927.09 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,772,934,304.72 |
Minority Stockholder's Interest |
32,364,395,274.57 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,676,685,856.59 |
Owner's Equity(Stockholder's Equity) |
48,041,081,131.16 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
206,133,549,131.39 |